SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-092603
Filing Date
2021-07-15
Accepted
2021-07-15 16:08:00
Documents
52
Period of Report
2021-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2122210d1_10q.htm 10-Q 530497
2 EXHIBIT 31.1 tm2122210d1_ex31-1.htm EX-31.1 12609
3 EXHIBIT 32.1 tm2122210d1_ex32-1.htm EX-32.1 4806
  Complete submission text file 0001104659-21-092603.txt   3667125

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT qbio-20210531.xml EX-101.INS 776167
5 XBRL TAXONOMY EXTENSION SCHEMA qbio-20210531.xsd EX-101.SCH 38861
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qbio-20210531_cal.xml EX-101.CAL 29696
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qbio-20210531_def.xml EX-101.DEF 159104
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE qbio-20210531_lab.xml EX-101.LAB 327429
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qbio-20210531_pre.xml EX-101.PRE 255884
Mailing Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017
Business Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017 212-588-0022
Q BioMed Inc. (Filer) CIK: 0001596062 (see all company filings)

IRS No.: 464013793 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 10-Q | Act: 34 | File No.: 000-55535 | Film No.: 211092794
SIC: 2834 Pharmaceutical Preparations